Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging

Objective The risk for symptomatic intracerebral hemorrhage (sICH) associated with thrombolytic treatment has not been evaluated in large studies using diffusion‐weighted imaging (DWI). Here, we investigated the relation between pretreatment DWI lesion size and the risk for sICH after thrombolysis....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of neurology 2008-01, Vol.63 (1), p.52-60
Hauptverfasser:	Singer, Oliver C., Humpich, Marek C., Fiehler, Jens, Albers, Gregory W., Lansberg, Maarten G., Kastrup, Andiras, Rovira, Alex, Liebeskind, David S., Gass, Achim, Rosso, Charlotte, Derex, Laurent, Kim, Jong S., Neumann-Haefelin, Tobias
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences Brain Infarction - drug therapy Brain Ischemia - complications Brain Ischemia - pathology Brain Ischemia - physiopathology Cerebral Arteries - drug effects Cerebral Arteries - pathology Cerebral Arteries - physiopathology Cerebral Hemorrhage - chemically induced Cerebral Hemorrhage - pathology Cerebral Hemorrhage - physiopathology Cerebrovascular Circulation - drug effects Cerebrovascular Circulation - physiology Diffusion Magnetic Resonance Imaging Female Fibrinolytic Agents - adverse effects Humans Intracranial Thrombosis - drug therapy Investigative techniques, diagnostic techniques (general aspects) Leukoaraiosis - chemically induced Leukoaraiosis - pathology Leukoaraiosis - physiopathology Male Medical sciences Middle Aged Nerve Fibers, Myelinated - drug effects Nerve Fibers, Myelinated - pathology Nervous system Neurology Predictive Value of Tests Prospective Studies Radiodiagnosis. Nmr imagery. Nmr spectrometry Retrospective Studies Risk Assessment Risk Factors Severity of Illness Index Thrombolytic Therapy - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!